SCHEMBL17827726

SCHEMBL17827726

NCc1ccc(-n2nnc3cnc(Nc4cnn(CCCC(=O)O)c4)nc32)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3A P49840 6/20 0.58
▸ GSK3B P49841 6/20 0.58
▸ AURKA O14965 4/20 0.58
▸ EIF2AK4 Q9P2K8 2/20 0.54
▸ JAK2 O60674 10/20 0.45
▸ HDAC6 Q9UBN7 9/20 0.45
▸ HDAC1 Q13547 2/20 0.45
▸ JAK1 P23458 1/20 0.45
▸ TYK2 P29597 1/20 0.45
▸ JAK3 P52333 1/20 0.45
▸ MAPK6 Q16659 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ HDAC3 O15379 1/20 0.42
▸ HDAC4 P56524 1/20 0.42
▸ HDAC7 Q8WUI4 1/20 0.42
▸ HDAC2 Q92769 1/20 0.42
▸ HDAC10 Q969S8 1/20 0.42
▸ HDAC11 Q96DB2 1/20 0.42
▸ HDAC8 Q9BY41 1/20 0.42
▸ HDAC9 Q9UKV0 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16245880 0.99 GSK3A (0.57) GSK3AGSK3BAURKAEIF2AK4JAK2
SCHEMBL16264890 0.88 EIF2AK4 (0.60) GSK3AGSK3BAURKAEIF2AK4JAK2
SCHEMBL18869417 0.88 GSK3A (0.51) GSK3AGSK3BAURKAEIF2AK4JAK2
Hydrochloric Acid SCHEMBL16246073 0.87 GSK3A (0.50) GSK3AGSK3BAURKAEIF2AK4JAK2
SCHEMBL16245882 0.87 EIF2AK4 (0.60) GSK3AGSK3BAURKAEIF2AK4JAK2
Hydrochloric Acid SCHEMBL17821173 0.86 EIF2AK4 (0.59) GSK3AGSK3BAURKAEIF2AK4JAK2
SCHEMBL16245597 0.85 EIF2AK4 (0.60) GSK3AGSK3BAURKAEIF2AK4JAK2
SCHEMBL16246069 0.84 EIF2AK4 (0.51) GSK3AGSK3BAURKAEIF2AK4JAK2
Hydrochloric Acid SCHEMBL17821184 0.84 EIF2AK4 (0.59) GSK3AGSK3BAURKAEIF2AK4JAK2
SCHEMBL17821181 0.84 GSK3A (0.66) GSK3AGSK3BAURKAEIF2AK4JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9861635-B2 Macrocycles as kinase inhibitors MERCK PATENT GMBH (DE) 2018-01-09 — — US disclosed
US-20160166574-A1 MACROCYCLES AS KINASE INHIBITORS MERCK PATENT GMBH (DE) 2016-06-16 — — US disclosed
US-20160166574-A1 MACROCYCLES AS KINASE INHIBITORS MERCK PATENT GMBH (DE) 2016-06-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160166574-A1 MACROCYCLES AS KINASE INHIBITORS EIF2AK4, CDK2, CDK1 GSK3A 523/4885GSK3B 482/4885AURKA 288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback